Is N-(2-Hydroxyethyl)-1-deoxynojirimycin Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use N-(2-Hydroxyethyl)-1-deoxynojirimycin? Is N-(2-Hydroxyethyl)-1-deoxynojirimycin safe for nursing mother and child? Does N-(2-Hydroxyethyl)-1-deoxynojirimycin extracts into breast milk? Does N-(2-Hydroxyethyl)-1-deoxynojirimycin has any long term or short term side effects on infants? Can N-(2-Hydroxyethyl)-1-deoxynojirimycin influence milk supply or can N-(2-Hydroxyethyl)-1-deoxynojirimycin decrease milk supply in lactating mothers?
N-(2-Hydroxyethyl)-1-deoxynojirimycin lactation summary
- DrLact safety Score for N-(2-Hydroxyethyl)-1-deoxynojirimycin is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of N-(2-Hydroxyethyl)-1-deoxynojirimycin is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that N-(2-Hydroxyethyl)-1-deoxynojirimycin does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of N-(2-Hydroxyethyl)-1-deoxynojirimycin safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About N-(2-Hydroxyethyl)-1-deoxynojirimycin usage in lactation
Alpha-glucosidase inhibitor which acts within the gastrointestinal tract without being absorbed, reducing intestinal absorption of glucose. Very low risk of hypoglycemia in monotherapy. N-(2-Hydroxyethyl)-1-deoxynojirimycin is excreted in breast milk in minute quantities (Serrano 2014, Pfizer 2012, AEMPS 2009) reaching a relative dose much less than 1%. Diet, exercise, and breastfeeding improve blood sugar levels.
Answer by DrLact: About N-(2-Hydroxyethyl)-1-deoxynojirimycin usage in lactation
Limited data indicate that N-(2-Hydroxyethyl)-1-deoxynojirimycin is poorly excreted into breastmilk. Because N-(2-Hydroxyethyl)-1-deoxynojirimycin is also poorly absorbed orally, it is unlikely to adversely affect the breastfed infant.
Alternate Drugs
Acarbose(Safe)
Saxagliptin(Low Risk)
Colesevelam(Safe)
Miglitol(Safe)
Tolbutamide(Safe)
Dulaglutide(Low Risk)
Rosiglitazone(Low Risk)
Repaglinide(Unsafe)
Liraglutide(Low Risk)
Pioglitazone(Low Risk)
Nateglinide(Unsafe)
Metformin(Safe)
Insulin(Safe)
Empagliflozin(Unsafe)
Glyburide(Safe)
Dapagliflozin(Unsafe)
Glipizide(Safe)
Alogliptin(Low Risk)
Glimepiride(Unsafe)
Chlorpropamide(Low Risk)
Linagliptin(Low Risk)
Acetohexamide(Low Risk)
Sitagliptin(Low Risk)